The Australian Health Practitioner Regulation Agency has released the terms of reference for an independent review on the use of chaperones to protect patients.
AHPRA is seeking submissions on the review, with AHPRA ceo Martin Fletcher saying the outcome will inform the ways in which the Medical Board of Australia and AHPRA can "strengthen the approach to protecting patients".
The above article was sent to subscribers in Pharmacy Daily's issue from 06 Sep 16
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 06 Sep 16
